On GLP-1 drugs, get comfortable with being uncomfortable The great thing about these drugs, says Kessler, is that they allow you to relearn how to eat
For more tips, see this blog post: 18 Common Mistakes to Avoid While Taking GLP-1s for Weight Loss When to Contact a Healthcare Provider Patients should know which symptoms require immediate medical attention
doi: 10.3390/nu8030128
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Semaglutide is a selective GLP-1 receptor agonist